| Literature DB >> 7222197 |
G L Moore, C C Peck, P R Sohmer, T F Zuck.
Abstract
Approval of the new anticoagulant preservative, CPDA-1, was based in part on data from human clinical trials of CPDA-1 performed by six cooperating laboratories and two blood bag manufacturers. Biochemical and red blood cell survival properties of 123 units of blood stored for 28 to 35 days in CPDA-1 (as reported by cooperating laboratories) are briefly summarized.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7222197 DOI: 10.1046/j.1537-2995.1981.21281178147.x
Source DB: PubMed Journal: Transfusion ISSN: 0041-1132 Impact factor: 3.157